Life-threatening pneumonia caused by macrolide-resistant Mycoplasma pneumoniae

Pediatr Infect Dis J. 2012 Feb;31(2):208-9. doi: 10.1097/INF.0b013e318234597c.

Abstract

Two siblings had pneumonia caused by macrolide-resistant Mycoplasma pneumoniae as determined by polymerase chain reaction and serology. One of them developed adult respiratory distress syndrome and required extracorporeal membrane oxygenation therapy. This report highlights the need for studies to evaluate the optimal treatment in severe cases of macrolide-resistant M. pneumoniae pneumonia.

Publication types

  • Case Reports

MeSH terms

  • Anti-Bacterial Agents / pharmacology*
  • Child
  • Drug Resistance, Bacterial*
  • Female
  • Humans
  • Macrolides / pharmacology*
  • Male
  • Mycoplasma pneumoniae / drug effects*
  • Mycoplasma pneumoniae / isolation & purification
  • Pneumonia, Mycoplasma / complications
  • Pneumonia, Mycoplasma / diagnosis*
  • Pneumonia, Mycoplasma / microbiology*
  • Pneumonia, Mycoplasma / pathology
  • Polymerase Chain Reaction
  • Respiratory Distress Syndrome / diagnosis
  • Respiratory Distress Syndrome / therapy
  • Respiratory Therapy
  • Serologic Tests

Substances

  • Anti-Bacterial Agents
  • Macrolides